Advances in Nanomedicine for Modulating DNA Methylation and Inducing Pyroptosis
Journal of Nanotheranostics · 05.06.2026 · 7 (2) · 14
DOI: 10.3390/jnt7020014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nanotheranostics, online erschienen am 05.06.2026. Verfasst von Shibo Wang und 6 weiteren Autor:innen. Die Arbeit nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Mu-nicipal Commission of Education.
Abstract (Originalsprache)
DNA methylation is a key mechanism in epigenetic regulation and plays a pivotal role in tumor initiation, progression, and therapeutic resistance. We begin by elucidating how the dysregulation of key DNA methylation enzymes in tumors drives concurrent global hypomethylation and cytosine-phosphate-guanine (CpG) island hypermethylation. This aberrant epigenetic landscape promotes tumorigenesis through silencing tumor suppressor genes and triggering abnormal activation of oncogenic signaling pathways. Notably, DNA methylation is intimately linked to cellular pyroptosis. In particular, the hypermethylation-mediated silencing of pyroptosis effector genes represents a critical epigenetic mechanism underlying acquired drug resistance. Targeting DNA methylation with epigenetic drugs offers a novel strategy to resensitize tumors to chemotherapy, radiotherapy, and immunotherapy. Moreover, advances in nanomedicine have yielded smart platforms for the precise administration of epigenetic modulators and combination therapies. These platforms enable a coordinated “epigenetic priming-pyroptosis execution” strategy, which holds promises for reversing therapeutic resistance and remodeling the tumor immune microenvironment. By integrating DNA methylation regulation, pyroptosis mechanisms, and nano-targeted strategies, this review aims to provide a theoretical framework and novel perspectives for developing innovative, epigenetically driven anti-tumor therapies.
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation Program and Scientific Research Key Program of Beijing Mu-nicipal Commission of Education
Zitieren
APA
Wang, S., Li, X., Liu, H., Zhang, J., Li, J., Jin, X., & Fang, C. (2026). Advances in Nanomedicine for Modulating DNA Methylation and Inducing Pyroptosis. Journal of Nanotheranostics, 7(2), 14. https://doi.org/10.3390/jnt7020014
Vancouver
Wang S, Li X, Liu H, Zhang J, Li J, Jin X, et al. Advances in Nanomedicine for Modulating DNA Methylation and Inducing Pyroptosis. Journal of Nanotheranostics. 2026;7(2):14. doi:10.3390/jnt7020014
BibTeX
@article{Wang2026,
author = {Wang, Shibo and Li, Xincong and Liu, Hao and Zhang, Jiali and Li, Jiaxi and Jin, Xu and Fang, Chenjie},
title = {Advances in Nanomedicine for Modulating DNA Methylation and Inducing Pyroptosis},
journal = {Journal of Nanotheranostics},
year = {2026},
volume = {7},
number = {2},
pages = {14},
doi = {10.3390/jnt7020014}
}
EUVIMED